FENO Guided Therapy in Asthma: A Non-inferiority Study

T. Kulkarni (Kolkata, India), A. Mukherjee (Kolkata, India), B. Biswas (Kolkata, India), A. Ghosal (Kolkata, India), R. Dhar (Kolkata, India)

Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Session: Eosinophils and FeNO in airway diseases
Session type: Oral Presentation
Number: 2153
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Kulkarni (Kolkata, India), A. Mukherjee (Kolkata, India), B. Biswas (Kolkata, India), A. Ghosal (Kolkata, India), R. Dhar (Kolkata, India). FENO Guided Therapy in Asthma: A Non-inferiority Study. 2153

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dupilumab Efficacy in Type 2 Inflammatory Asthma: Liberty Asthma QUEST Study
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019



Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


e-Monitoring of Asthma Therapy to Improve Compliance in children (e-MATIC): a randomised controlled trial
Source: Eur Respir J 2016; 48: 758-767
Year: 2016



Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021

Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020


Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT
Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2018




Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017

Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017


Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study
Source: International Congress 2019 – Clinical studies of asthma treatments
Year: 2019


Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Effects of MACVIA-ARIA Sentinel Network for Allergic Rhinitis (MASK-Air) Mobile Phone Application on Asthma Control in Patients with Asthma
Source: Virtual Congress 2020 – Management of allergy, asthma and COPD
Year: 2020


Interdisciplinary Pilot Project on Emphysema Quantification and Bronchial Wall Thickness assessment in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018


Guideline Adherence and Identifying Cost Effective Medication
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014

Co-Morbidities Are Serious Confounders of Asthma in Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007


Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018



Barriers to Exercise in Difficult Asthma in the WATCH Cohort
Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases
Year: 2020


Long-Acting Beta Agonist Asthma Pharmacogenetic Loci Identified in Two Multi-Racial Asthma Clinical Trials
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021